INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 43h ago
House PTR3h ago
SEC 13F3h ago
Robinhood Chain3h ago

Results

82,097 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
SI
Stefan Constantin IonelChief Technology Officer
AMPXAmprius Technologies, Inc.
Option exercise
M—
15.9K sh
Jan 21, 2026
Page 1677 of 2053
← PrevNext →
Jan 23, 2026
traded Jan 21, 2026
+2d
SEC Form 4

Evidence

9
BR
Bensoussan Torres RobertDirector
IPARINTERPARFUMS INC
Option exercise
M—
375 sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC Form 4

Evidence

9
BE
Buck ElizabethCHIEF SCIENTIFIC OFFICER
BDTXBlack Diamond Therapeutics, Inc.
Grant or award
A—
250.0K sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

9
FT
Fitzgerald TraeChief Financial Officer
VMDVIEMED HEALTHCARE, INC.
Disposition to issuer
D$25K
3,329 sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

8
BT
Beer Michael ThomasChief Financial Officer
NRGVEnergy Vault Holdings, Inc.
Tax withholding
F$72K
15.7K sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC Form 4

Evidence

7
EB
Edris BadreddinDirector
EWTXEdgewise Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$20K
10.5K sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

6
Farquhar ScottDirector, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$56K
450 sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC Form 4

Evidence

6
HW
Hanna John Walter JRDirector, President and CEO
CDNACareDx, Inc.
Open-market sale · 10b5-1 plan
SELL$4,200
200 sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

6
Farquhar ScottDirector, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$197K
1,551 sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC Form 4

Evidence

6
CM
Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$99K
800 sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC Form 4

Evidence

6
Farquhar ScottDirector, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$100K
784 sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC Form 4

Evidence

6
Farquhar ScottDirector, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$94K
730 sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC Form 4

Evidence

6
Farquhar ScottDirector, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$99K
800 sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC Form 4

Evidence

6
CM
Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$56K
450 sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC Form 4

Evidence

6
CM
Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$94K
730 sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC Form 4

Evidence

6
CM
Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$100K
784 sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC Form 4

Evidence

6
CM
Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$197K
1,551 sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC Form 4

Evidence

5
SI
Stefan Constantin IonelChief Technology Officer
AMPXAmprius Technologies, Inc.
Option exercise
M$794
15.9K sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

5
SI
Stefan Constantin IonelChief Technology Officer
AMPXAmprius Technologies, Inc.
Option exercise
M—
72.8K sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC Form 4

Evidence

5
SI
Stefan Constantin IonelChief Technology Officer
AMPXAmprius Technologies, Inc.
Option exercise
M—
1,600 sh
Jan 23, 2026Jan 23, 2026
traded Jan 23, 2026
+0dSEC Form 4

Evidence

5
SI
Stefan Constantin IonelChief Technology Officer
AMPXAmprius Technologies, Inc.
Option exercise
M—
253.9K sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC Form 4

Evidence

5
SH
Schingler Robert HDirector, Co-Founder Chief Strategy Off.
PLPlanet Labs PBC
Option exercise
M—
292.0K sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

5
SH
Schingler Robert HDirector, Co-Founder Chief Strategy Off.
PLPlanet Labs PBC
Option exercise
M—
36.4K sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

5
Marshall William SpencerDirector, Co-Founder and CEO
PLPlanet Labs PBC
Option exercise
M—
292.0K sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

5
SI
Stefan Constantin IonelChief Technology Officer
AMPXAmprius Technologies, Inc.
Option exercise
M—
166.1K sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC Form 4

Evidence

5
SI
Stefan Constantin IonelChief Technology Officer
AMPXAmprius Technologies, Inc.
Option exercise
M$80
1,600 sh
Jan 23, 2026Jan 23, 2026
traded Jan 23, 2026
+0dSEC Form 4

Evidence

5
Marshall William SpencerDirector, Co-Founder and CEO
PLPlanet Labs PBC
Option exercise
M—
123.9K sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

5
SI
Stefan Constantin IonelChief Technology Officer
AMPXAmprius Technologies, Inc.
Option exercise
M—
41.6K sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

5
SI
Stefan Constantin IonelChief Technology Officer
AMPXAmprius Technologies, Inc.
Option exercise
M$792
15.8K sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

5
FA
Flees Lori AnnDirector, President & CEO
VVVVALVOLINE INC
Grant or award
A$963
29 sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC Form 4

Evidence

3
GE
Gilliam Joseph EPRESIDENT & COO
GKOSGLAUKOS Corp
Option exercise · 10b5-1 plan
M—
1,900 sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

3
EB
Edris BadreddinDirector
EWTXEdgewise Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$5,400
7,605 sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

2
GE
Gilliam Joseph EPRESIDENT & COO
GKOSGLAUKOS Corp
Option exercise · 10b5-1 plan
M$248K
4,502 sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

2
BS
Beatty Jonathan SMD, Head of Advisor Services
SCHWSCHWAB CHARLES CORP
Option exercise · 10b5-1 plan
M$93K
2,000 sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC Form 4

Evidence

1
MM
Murphy Scott MChief Accounting Officer
RPDRapid7, Inc.
Open-market sale · 10b5-1 plan
SELL$9,703
764 sh
Jan 22, 2026Jan 23, 2026
traded Jan 22, 2026
+1dSEC Form 4

Evidence

0
EB
Edris BadreddinDirector
EWTXEdgewise Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
10.5K sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

0
EB
Edris BadreddinDirector
EWTXEdgewise Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
13.7K sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

0
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
281.3K sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

0
EB
Edris BadreddinDirector
EWTXEdgewise Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
66.5K sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence

0
EB
Edris BadreddinDirector
EWTXEdgewise Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
17.2K sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC Form 4

Evidence